Transthoracic and transoesophageal echocardiography (TTE, TEE) were performed in 130 consecutive patients referred for mitral balloon valvotomy. Atrial septal aneurysms were diagnosed by TTE and TEE in 2 and 3 patients, respectively. All 3 patients underwent mitral balloon valvotomy via the transseptal route. The foramen ovale was found to be patent in 2 of these patients, thus rendering puncture of the interatrial septum unnecessary. In the 3rd patient transseptal catheterisation was performed through the wall of the aneurysm itself. There were no significant complications in any of these patients. No left-to-right interatrial shunting could be demonstrated by oximetry in any of the 3 patients. Transoesophageal colour flow imaging showed trivial shunting in 2 patients and none in the 3rd. Transseptal mitral balloon valvotomy can be performed safely in patients with atrial septal aneurysms, especially in those with co-existent patent foramen ovale.

Keywords:
Mitral balloon valvotomy, Atrial septal aneurysm, Transesophageal echocardiography, Patent foramen ovale
This content is only available via PDF.
© 1997 S. Karger AG, Basel
1997
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.